ArticleCurrent opinion in biomedical engineering2022
A review of co-registered transvaginal photoacoustic and ultrasound imaging for ovarian cancer diagnosis.
Article in Current opinion in biomedical engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 8 citations in OpenAlex.
- High-Speed Volumetric Dual-Mode Ultrasound and Photoacoustic Tomography With a Single-Element Detector.IEEE transactions on medical imaging · 2026Article
- Early identification of umbilical blood flow restriction and maternal placental hypoperfusion with photoacoustic imaging.Photoacoustics · 2026Article
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens.Cancers · 2025Review
- Histological and photoacoustic evaluation of rectal cancer after neoadjuvant therapy using microvascular density.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2024Article
- Photoacoustic imaging plus X: a review.Journal of biomedical optics · 2024Review
- Dual-modal Photoacoustic and Ultrasound Imaging: from preclinical to clinical applications.Frontiers in photonics · 2024Article
- Advances in photoacoustic imaging aided by nano contrast agents: special focus on role of lymphatic system imaging for cancer theranostics.Journal of nanobiotechnology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Ovarian cancer is the deadliest of all gynecological malignancies. When ovarian cancer is detected at an early, localized stage, surgery and chemotherapy can cure 70%-90% of patients, compared with 20% or fewer when it is diagnosed at later stages. Clearly, early detection is critical, yet the lack of early symptoms and effective screening tools means that only 20-25% of ovarian cancers are diagnosed early. Photoacoustic imaging (PAI) is an emerging modality that uses a short-pulsed laser to excite tissue. The resulting photoacoustic waves are used to image tissue optical contrast, which is directly related to tissue microvasculature and thus to cancer growth. When co-registered with transvaginal ultrasound (US), PAI offers great promise in diagnosing earlier stage ovarian cancers and distinguishing benign processes from malignant ovarian masses. In this article, we review the limitations of the current imaging tools for early ovarian cancer diagnosis and present recent advances in co-registered PAI/US.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.